Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)

SHE:002793 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	5,233	4,055	5,829	8,342	15,181	15,215
Market Cap Growth	33.60%	-30.44%	-30.12%	-45.05%	-0.22%	-
Enterprise Value	6,193	5,305	6,876	11,056	16,161	15,869
Last Close Price	4.93	3.82	5.36	7.67	10.34	10.29
PE Ratio	-	-	-	-	37.38	47.44
PS Ratio	2.10	1.53	2.47	2.33	2.34	2.50
PB Ratio	3.42	2.78	2.27	2.52	3.21	3.50
P/TBV Ratio	5.31	4.54	2.93	3.00	3.76	4.13
P/FCF Ratio	21.75	-	25.97	-	-	-
P/OCF Ratio	18.38	-	12.49	-	125.85	-
EV/Sales Ratio	2.49	2.00	2.91	3.08	2.50	2.60
EV/EBITDA Ratio	124.17	-	-	-	22.90	27.03
EV/EBIT Ratio	-	-	-	-	31.10	38.11
EV/FCF Ratio	25.74	-	30.63	-	-	-
Debt / Equity Ratio	0.91	1.12	0.59	1.10	0.60	0.33
Debt / EBITDA Ratio	28.00	-	-	-	3.97	2.47
Debt / FCF Ratio	5.80	-	6.77	-	-	-
Net Debt / Equity Ratio	0.58	0.81	0.32	0.66	0.17	0.04
Net Debt / EBITDA Ratio	23.93	-4.14	-2.86	-1.56	1.17	0.28
Net Debt / FCF Ratio	3.67	-4.33	3.68	-1.91	-4.37	-0.42
Asset Turnover	0.56	0.56	0.36	0.41	0.75	0.80
Inventory Turnover	3.02	3.51	2.35	3.86	4.77	4.11
Quick Ratio	0.58	0.48	0.79	0.85	1.34	1.34
Current Ratio	0.81	0.70	1.08	1.08	1.59	1.65
Return on Equity (ROE)	-38.06%	-52.20%	-26.16%	-31.26%	9.28%	8.20%
Return on Assets (ROA)	-2.17%	-6.31%	-4.53%	-11.35%	3.77%	3.43%
Return on Invested Capital (ROIC)	-6.81%	-15.79%	-10.81%	-28.99%	8.96%	8.54%
Return on Capital Employed (ROCE)	-8.00%	-26.50%	-15.00%	-42.70%	9.50%	8.80%
Earnings Yield	-12.94%	-23.81%	-11.34%	-14.68%	2.67%	2.11%
FCF Yield	4.60%	-6.74%	3.85%	-13.59%	-1.24%	-2.59%
Dividend Yield	-	-	-	-	0.29%	0.49%
Payout Ratio	-	-	-	-	32.59%	42.43%
Buyback Yield / Dilution	0.78%	2.11%	23.91%	1.79%	0.51%	-31.07%
Total Shareholder Return	0.78%	2.11%	23.91%	1.79%	0.80%	-30.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.